3′-azido-3′-deoxythymidine cytotoxicity and metabolism in the human colon tumor cell line HCT-8

This publication has 19 references indexed in Scilit:

• Hydroxyurea enhances 3′‐azido‐3′‐deoxythymidine (AZT) cytotoxicity in human chronic myeloid leukemia models*
  European Journal of Haematology, 1994
• Combination studies with 3′-azido-3′-deoxythymidine (AZT) plus ICI D1694
  Biochemical Pharmacology, 1993
• High-dose intravenous zidovudine with 5-fluorouracil and leucovorin. A phase I trial
  Cancer, 1992
• Tissue-specific expansion of uridine pools in mice: Effects of benzylacyclouridine, dipyridamole and exogenous uridine
  Biochemical Pharmacology, 1991
• AZT: A Biochemical Response Modifier of Methotrexate and 5-Fluorouracil Cytotoxicity in Human Ovarian and Pancreatic Carcinoma Cells
  Cancer Communications, 1991
• Azidothymidine Inhibition of Thymidine Kinase and Synergistic Cytotoxicity with Methotrexate and 5-Fluorouracil in Rat Hepatoma and Human Colon Cancer Cells
  Cancer Communications, 1990
• Effects of 3′-azido-3′-deoxythymidine on the deoxynucleotide triphosphate pools of cultured human cells
  Biochemical and Biophysical Research Communications, 1988
• The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related Complex
  New England Journal of Medicine, 1987
• Use of periodate and methylamine for the quantitation of intracellular 5-fluro-2′-deoxyuridine-5′-monophosphate by high-performance liquid chromatography
  Journal of Chromatography A, 1981
• Cultural and Antigenic Properties of Newly Established Cell Strains Derived From Adenocarcinomas of the Human Colon and Rectum
  JNCI Journal of the National Cancer Institute, 1974